New Drug Slows Progression of Dry Age-Related Macular Degeneration

New Drug Slows Progression of Dry Age-Related Macular Degeneration | Boulder Peptide Symposium

September 15-18, 2025

LIVE, In Person at the St. Julien Hotel in Boulder, Colorado

The only conference focused solely on the pharmaceutical development of peptide therapeutics.

New Drug Slows Progression of Dry Age-Related Macular Degeneration

Peptide News from Biotech and Pharma, Raw News October 11, 2017

“APL-2 is a synthetic cyclic peptide conjugated to a polyethylene glycol polymer that binds specifically to C3 and C3b, effectively blocking all three ...